Single center validation of routine blastocyst biopsy implementation
Open Access
- 20 August 2016
- journal article
- assisted reproduction-technologies
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 33 (11) , 1507-1513
Abstract
Purpose The study aims to contrast the efficacy of trophectoderm biopsy preimplantation genetic screening (PGS)/vitrification (VTF)-all cycles to past treatment protocols. Specifically, do these applied technologies increase live birth rates on a per cycle/first transfer basis? Materials and methods An observational, retrospective cohort study of first transfer outcomes was performed in two groups. Group 1 (PGS) included PGS/VTF-all cycles, and group 2 (no PGS) included the first transfer from non-PGS fresh cycles or VTF-ALL cycles. In group 1, all blastocysts were biopsied on days 5/6, vitrified and array CGH performed. Group 2 patients had embryo transfers on day 3 or day 5. All blastocysts were vitrified and warmed according to μS-VTF protocols. Clinical pregnancies and implantation were confirmed by ultrasound and live birth information attained. Results were stratified by age with donor cycles excluded, and to eliminate bias, the same groups were then validated on a per cycle basis. Chi-squared used to determine significance. Results Analyzing 287 embryo transfers and 1,000+ PGS-tested blastocysts, an overall 97 % increase in live births favored group 1 (PGS). When utilizing PGS/VTF-ALL cycles, patients under 43 years old exhibited higher implantation, clinical pregnancy, and ongoing/live birth rates. Re-analyzing the data to include all cycles initiated revealed higher live birth rates in group 1 age groups ≤34 and 38–40 years old. Conclusion Validating PGS on a per cycle basis eliminated data bias by including patients without blastocysts to biopsy or euploid embryos. Clearly, PGS uses blastocysts more efficiently to achieve success, while many women over 40 may benefit most by understanding why some failures occur. Support NoneKeywords
Funding Information
- Study supported by internal funds: Southern California Institutes for Reproductive Sciences
This publication has 13 references indexed in Scilit:
- Validation of microSecure vitrification (μS-VTF) for the effective cryopreservation of human embryos and oocytesCryobiology, 2015
- Clinical validation of embryo culture and selection by morphokinetic analysis: a randomized, controlled trial of the EmbryoScopeFertility and Sterility, 2014
- Assessing morphokinetic parameters via time lapse microscopy (TLM) to predict euploidy: are aneuploidy risk classification models universal?Journal of Assisted Reproduction and Genetics, 2014
- Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trialFertility and Sterility, 2013
- Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trialFertility and Sterility, 2013
- Array comparative genomic hybridization screening in IVF significantly reduces number of embryos available for cryopreservationClinical and Experimental Reproductive Medicine, 2012
- Final ART success rates: a 10 years surveyHuman Reproduction, 2011
- Vitrified-warmed blastocyst transfer cycles yield higher pregnancy and implantation rates compared with fresh blastocyst transfer cycles—time for a new embryo transfer strategy?Fertility and Sterility, 2011
- What is the most relevant standard of success in assisted reproduction?: The next step to improving outcomes of IVF: consider the whole treatmentHuman Reproduction, 2004
- Changes in requirements and utilization of nutrients during mammalian preimplantation embryo development and their significance in embryo cultureTheriogenology, 1998